GTR Home > Tests > Search results - C0220769[DISCUI]

Apply filters

Showing tests for all 669 conditions

Compare labs

  • Hide states

GTR test search results for C0220769[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 28 tests for 669 conditions in 18 labs

COpitz-Kaveggia syndrome

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFG syndrome type 1

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CMacrocephaly Sequencing Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (14)

CLujan Syndrome, FG Syndrome Type 1 and Ohdo Syndrome via the MED12 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CX-Linked Intellectual Disability Panel, Sequencing, 76 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (127)
Total targets (76)

CMED12

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAutism & Intellectual Disability NGS Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (103)
Total targets (82)

CFG syndrome

Lab: Invitae San Francisco, California, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAutism Panel: Tier 2

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (102)
Total targets (60)

CX-linked Intellectual Disability: Gene Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (140)
Total targets (92)

CCardiomyopathy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (229)
Total targets (104)

CXLID NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (188)
Total targets (107)

CEpileptic syndromes with epilepsy and intellectual disability panel

Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (75)
Total targets (50)

CAutism NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (177)
Total targets (100)

COpitz-Kaveggia syndrome

Lab: MedGene Bratislava, Bratislava, Slovakia
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

COpitz-Kaveggia Syndrome (sequence analysis of MED12 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

COpitz-Kaveggia syndrome

Lab: Praxis fuer Humangenetik Wien Vienna, Wien, Austria
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 28 tests for 669 conditions in 18 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk